Hand dermatitis, also known as hand eczema (HE), is the most common skin disorder affecting the hands. It is not a homogeneous disease, and it can occur in many and various forms either for clinical presentation or for severity. A wide range of clinical presentation has been reported: from mild, acute, and self-limiting forms to chronic and severe, refractory to treatment.
- Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, Kaszuba A, Bissonnette R, Varjonen E, Holló P, Cambazard F, Lahfa M, Elsner P, Nyberg F, Svensson A, Brown TC, Harsch M, Maares J. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol. 2008;158(4):808–17.PubMedGoogle Scholar
- Cortesi PA, Scalone L, Giannetti A, Angelini G, Belisari A, Cannavò SP, Cristaudo A, De Pità O, Gallo R, Gola M, Pigatto P, Mantovani LG; for the Italian Hand Eczema Study Group. Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids. Contact Dermatitis. 2014;70(3):158–68.Google Scholar
- Gola M, D’Erme AM, Milanesi N, Marmugi L. Effects of alitretinoin on quality of life of patients suffering from chronic hand eczema: an observational study. Dermatitis. 2013;24(4):166–9.Google Scholar
- Gola M, Milanesi N, D’Erme AM. Clinical evaluation and assessment of the therapeutic effectiveness of alitretinoin in a group of patients with chronic hand eczema refractory to topical steroid therapy. G Ital Dermatol Venereol. 2014;149(4):435–9.Google Scholar